Catalyst says it sees evidence its drug vigabatrin is effective despite failures; study surges
October 2, 2009 By Leave a Comment
More info…
Catalyst plans more tests of anti-addiction drug NEW YORK ? Catalyst Pharmaceutical Partners Inc. says it will continue developing an anti-addiction drug that has failed in two clinical trials, as it believes the treatment is safe and effective. Catalyst said its drug vigabatrin failed as a treatment for cocaine addiction because patients in the trial did not …